60 mg dose ticagrelor provides stronger platelet inhibition than clopidogrel in Chinese patients with chronic coronary syndrome: A randomized, single-blind, crossover study
Thrombosis Research(2020)
Abstract
•This was a randomized, single-blind, cross-over study in Chinese patients.•Ticagrelor exhibits more potent antiplatelet aggregation compared with clopidogrel.•60 mg QD ticagrelor had a stronger inhibitory effect than clopidogrel.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined